Skip to Content

Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine Pregnancy and Breastfeeding Warnings

Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine is also known as: Hycomine Compound

Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine Pregnancy Warnings

Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine Breastfeeding Warnings

There are no data on the excretion of acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother

See references

References for pregnancy information

  1. "Product Information. Hycomine Compound (APAP/caffeine/CPM/hydrocodone/PE)." Endo Laboratories LLC, Chadds Ford, PA.

References for breastfeeding information

  1. "Product Information. Hycomine Compound (APAP/caffeine/CPM/hydrocodone/PE)." Endo Laboratories LLC, Chadds Ford, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide